BTG (company)
http://dbpedia.org/resource/BTG_(company) an entity of type: Thing
BTG (früher British Technology Group) ist ein britisches Unternehmen, das sich auf die Lizenzierung und Vermarktung medizinischer Entwicklungen spezialisiert hat. Die Firma entstand aus der Fusion der National Research Development Corporation und des National Enterprise Board und ist an der Londoner Börse im FTSE 250 Index gelistet.
rdf:langString
BTG Limited is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders. The current name was adopted when the British Technology Group changed its name on 27 May 1998. BTG was a constituent of the FTSE 250 Index until it was acquired by Boston Scientific in August 2019.
rdf:langString
rdf:langString
BTG (Medizintechnikunternehmen)
rdf:langString
BTG (company)
rdf:langString
BTG Limited
rdf:langString
BTG Limited
xsd:integer
40626308
xsd:integer
1101660325
xsd:integer
1991
rdf:langString
Garry Watts , Louise Makin , Duncan Kennedy
rdf:langString
London, United Kingdom
rdf:langString
BTG plc.svg
xsd:integer
90
rdf:langString
Development, manufacturing and commercialisation of specialty pharmaceuticals and interventional medicine in the areas of critical care, cancer and varicose veins. BTG also has a revenue stream from royalty payments on partnered products.
<poundSterling>
6.205E8
rdf:langString
BTG (früher British Technology Group) ist ein britisches Unternehmen, das sich auf die Lizenzierung und Vermarktung medizinischer Entwicklungen spezialisiert hat. Die Firma entstand aus der Fusion der National Research Development Corporation und des National Enterprise Board und ist an der Londoner Börse im FTSE 250 Index gelistet.
rdf:langString
BTG Limited is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders. The current name was adopted when the British Technology Group changed its name on 27 May 1998. BTG was a constituent of the FTSE 250 Index until it was acquired by Boston Scientific in August 2019.
xsd:nonNegativeInteger
7444
xsd:gYear
1991
<poundSterling>
6.205E8